Jean Chamoun
About Jean Chamoun
Jean Chamoun is a Senior Director at Alkermes in Waltham, Massachusetts, with extensive experience in protein science and therapeutics.
Company
Jean Chamoun is a Senior Director at Alkermes, a biopharmaceutical company based in Waltham, Massachusetts, United States. Alkermes specializes in developing innovative medicines in the fields of neuroscience and oncology. Jean has been associated with Alkermes in various capacities over the years, contributing significantly to the company's research and development efforts.
Title
Currently, Jean Chamoun holds the title of Senior Director at Alkermes in Waltham, MA. Before this role, Jean served as Director for five months and Principal Scientist for two years at the same company. Jean's career at Alkermes also includes a stint as a Postdoctoral Fellow from 2011 to 2012.
Education
Jean Chamoun earned an MBA from the Isenberg School of Management, UMass Amherst, completing the program from 2017 to 2020. Jean also holds a PhD in Biophysics from Florida State University, earned over a span of six years from 2002 to 2008. Additionally, Jean completed a Bachelor's degree in Biology from AUB, from 1997 to 2002.
Background in Industry and Academia
Jean Chamoun’s professional journey includes significant roles at Alkermes and Pfizer. At Pfizer, Jean served as Principal Scientist from 2014 to 2019 and as Senior Scientist from 2012 to 2014. In academia, Jean was a Joint Postdoc at Florida State University, working at the NHMFL and Macquarie University in Sydney, Australia, from 2008 to 2011. These diverse experiences across both academic and industrial settings have provided Jean with a broad perspective on protein science.
Expertise in Protein Therapeutics
Jean Chamoun has extensive experience in protein expression, purification, and characterization, as well as molecular biology, cell culture, and protein engineering. Jean has been instrumental in the development of protein therapeutics at Alkermes. This expertise is complemented by a strong background in biophysics, aiding in Jean's role of leading scientific teams and projects focused on protein therapeutics.